Previous studies have reported that nasal administration of mycobacterial HSP60 peptide induces highly effective protection against adjuvant-induced arthritis (AA), an experimental arthritis model with close histopathologic resemblance to RA [7,8]. The gene discussed is HSPD1; the disease is Arthritis.